Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age19+
SponsorJW Pharmaceutical
About this trial
A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia
Eligibility criteria
Qualifiers
Patients with hypertension and dyslipidemia
Disqualifiers
The subject not meet the specified msBP and LDL-C level
Trial design
Treatments tested in this trial
- JW0104+C2402
- JW0104+C2403
- C2402
Treatment groups
162 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov